Review of Charts From Amish/Mennonite Variant PA Patients

Status Completed

Clinical Trial Summary

The natural history of patients with PA-AMV has not been systematically studied before and there is no published data in the literature about this condition since 1980. There is no evidence-based approach to care of these patients, particularly the younger patients who may no come to medical attention until significant cardiac problems develop. Through systematic review of existing medical records on essentially all known patient with this condition, investigators plan to develop an evidence-based management plan for preventive care of these patients.

Clinical Trial Description

The study is designed to provide a comprehensive description of the clinical and biochemical features of propionic academia, Amish/Mennonite variant (PA-AMV). From these data, the investigators hope to identify biomarkers for assessment of clinical course and efficacy of ongoing management. The investigators plan to identify essentially all known patients who have the Amish/Mennonite variant of Propionic academia (PA-AMV) through collaboration with clinicians who proved care to this extended community. Signed consents include permission to access life-long medical records to allow investigators to define the natural history of this biochemical variant condition. This will include a description the clinical and biochemical features and natural history of patients with propionic acidemia in the Amish/Mennonite population. In particular, there is interest in the cardiac complications of this variant, so investigators will analyze EKG, echo and cardiac MRI findings in above patients. These data will be used to Identify biomarkers for clinical assessment and ongoing management. There has been no published data on patients with PA-AMV since 1980. Accumulated clinical experience with PA Amish/Mennonite variant patients suggests that these patients tend to have less severe clinical features compared to classic PA. Severe neonatal metabolic decompensation and ketoacidosis are not present in Amish/Mennonite patients we have followed. Describing the natural history and clinical course is essential in this group of patients to further guide their management. There is currently no evidence-based approach to care of these patients, but rather individual medical centers manage patients symptomatically and differently. A uniform, data-driven approach to patient management is needed. ;

Study Design

Related Conditions & MeSH terms

Propionic Acidemia

Clinical Trial Details

NCT number	NCT03159026
Study type	Observational
Source	University of Pittsburgh
Contact
Status	Completed
Phase
Start date	April 6, 2017
Completion date	September 5, 2022

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05842837` - A Non-Interventional Post-Authorization Study of Carbaglu for the Treatment of Hyperammonemia Due to MMA and PA
Recruiting	`NCT05687474` - Baby Detect : Genomic Newborn Screening
Enrolling by invitation	`NCT03655223` - Early Check: Expanded Screening in Newborns
Recruiting	`NCT05130437` - A Long-Term Extension Study to Evaluate the Safety and Clinical Activity of mRNA-3927	Phase 1/Phase 2
Recruiting	`NCT02890342` - Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Completed	`NCT02426775` - Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia	Phase 3
Terminated	`NCT04836494` - A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia	Phase 1
Completed	`NCT03484767` - "The MaP Study": Mapping the Patient Journey in MMA and PA
Terminated	`NCT04732429` - Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia	Phase 2
Recruiting	`NCT05040178` - An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
Recruiting	`NCT05769621` - A Retrospective Study to Characterize Participants With Propionic Acidemia
Completed	`NCT00645879` - Anaplerotic Therapy in Propionic Acidemia	Phase 1
Recruiting	`NCT04176523` - Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Withdrawn	`NCT01341379` - Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate	Phase 2
Terminated	`NCT05438485` - Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia
Recruiting	`NCT04159103` - Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.